ArticleApplied microbiology and biotechnology2025
Phosphoserine phosphatase B facilitates indole metabolism to indole-3-lactic acid.
Article in Applied microbiology and biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Alterations in gut microbiota among maintenance hemodialysis patients with CKD-associated pruritus: a cross-sectional comparative study of two cohorts.Frontiers in cellular and infection microbiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Intestinal bacteria can convert indole to a range of compounds; however, the precise enzymatic processes facilitating this conversion have not been fully elucidated. Certain Bifidobacterium strains convert exogenous indole to indole-3-lactic acid (ILA) via tryptophan synthase beta chain and aromatic lactate dehydrogenase. Moreover, the metabolism of indole is enhanced when the strain is combined with non-digestible oligosaccharides, forming synbiotics. However, the mechanism by which synbiotics enhance indole metabolism remains unclear. Here, the conversion of indole to ILA was investigated in the context of synbiotic-mediated enhancement. The combination of Bifidobacterium bifidum YIT 10347 and galactooligosaccharides (non-digestible oligosaccharides) in human fecal suspension medium synergistically increased this conversion. Screening Tn5 transposon-mutated B. bifidum YIT 10347 clones revealed that phosphoserine phosphatase B (PSP), encoded by serB, and tryptophan synthase alpha chain (TrpA), encoded by trpA, play crucial roles in indole metabolism. Mutant strains lacking either PSP or TrpA showed a significant reduction in ILA production, confirming the roles of PSP and TrpA in this pathway. Additionally, serine supplementation restored ILA production in PSP-deficient strains, further supporting the role of serine biosynthesis in indole metabolism. These results suggest that PSP and TrpA play a vital role in the metabolism of indole to ILA. This study provides novel insights into microbial indole metabolism and suggests potential applications of synbiotics in improving health. KEY POINTS: • PSP and TrpA are essential for indole metabolism • Bifidobacterium bifidum YIT 10347 and GOS synergistically metabolize indole to ILA • This pathway offers potential therapeutic benefits for gut and kidney health.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.